Reproduction   citetrack
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS  

Reproduction (2007) 133 1005-1016
DOI: 10.1530/REP-06-0107
Copyright © 2007 Society for Reproduction and Fertility
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zerani, M
Right arrow Articles by Boiti, C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zerani, M
Right arrow Articles by Boiti, C

RESEARCH

Intraluteal regulation of prostaglandin F2{alpha}-induced prostaglandin biosynthesis in pseudopregnant rabbits

M Zerani1, C Dall’Aglio2, M Maranesi3, A Gobbetti1, G Brecchia3, F Mercati2 and C Boiti3

1 Dipartimento di Biologia Molecolare, Cellulare e Animale, Università di Camerino, via F. Camerini 1, I-62032 Camerino, Italy, Dipartimento di Scienze biopatologiche ed Igiene delle produzioni animali e alimentari, 2 Sezione di Anatomia veterinaria and 3 Laboratorio di Biotecnologie fisiologiche, Sezione di Fisiologia veterinaria, Università degli Studi di Perugia, via S. Costanzo 4, I-06100 Perugia, Italy

Correspondence should be addressed to C Boiti; Email: cristiano.boiti{at}unipg.it

The objective of the present study was to investigate in rabbit corpora lutea (CL), at both the cellular and molecular level, intraluteal cyclooxygenase (COX)-1, COX-2 and prostaglandin (PG) E2-9-ketoreductase (PGE2-9-K) enzymatic activities as well as in vitro PGE2 and PGF2{alpha} synthesis following PGF2{alpha} treatment at either early- (day-4) or mid-luteal (day-9) stage of pseudopregnancy. By immunohistochemistry, positive staining for COX-2 was localized in luteal and endothelial cells of stromal arteries at both the stages. In CL of both stages, basal COX-2 mRNA levels were poorly expressed, but rose (P < 0.01) 4- to 10-fold 1.5–6 h after treatment and then gradually decreased within 24 h. Compared to mid-stage, day-4 CL had lower (P < 0.01) COX-2 and PGE2-9-K basal activities, and PGF2{alpha} synthesis rate, but higher (P < 0.01) PGE2 production. Independent of luteal stage, PGF2{alpha} treatment did not affect COX-1 activity. In day-4 CL, PGF2{alpha} induced an increase (P < 0.01) in both COX-2 activity and PGF2{alpha} synthesis, whereas that of PGE2 remained unchanged. In day-9 CL, PGF2{alpha} up-regulated (P < 0.01) both COX-2 and PGE-9-K activities, and PGF2{alpha} production, but decreased (P < 0.01) PGE2 synthesis. All changes in gene expression and enzymatic activities occurred within 1.5 h after PGF2{alpha} challenge and were more marked in day-9 CL. Our data suggest that PGF2{alpha} directs intraluteal PG biosynthesis in mature CL, by affecting the CL biosynthetic machinery to increase the PGF2{alpha} synthesis in an auto-amplifying manner, with the activation of COX-2 and PGE-9-K; this may partly explain their differentially, age-dependent, luteolytic capacity to exogenous PGF2{alpha} in rabbits.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS  
Copyright © 2007 by the Society for Reproduction and Fertility.